Trials / Active Not Recruiting
Active Not RecruitingNCT03484884
A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
A Feasibility Study of Non-Invasive Cerenkov Luminescence Imaging in Patients With Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test Cerenkov luminescence imaging, which is a different way to take pictures of thyroid cancer and/or any tumors with (existing or suspected) nodal metastases in the neck, supraclavicular, axillary and/or inguinal region.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Cerenkov luminescence imaging. | Cerenkov luminescence imaging will be obtained from MSKCC patients who are scheduled for routine FDG PET scan or 131I therapy that emit a continuum of ultraviolet and visible light from the decay of certain radionuclides. |
Timeline
- Start date
- 2018-03-20
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2018-04-02
- Last updated
- 2026-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03484884. Inclusion in this directory is not an endorsement.